Medinet Co., Ltd. Reports Earnings Results for the Period Ended September 30, 2019; Provides Non Consolidated Earnings Guidance for the Year Ending of September 2020
November 08, 2019 at 11:30 am IST
Share
MEDINET Co., Ltd. reported earnings results for the period ended September 30, 2019. For the period, on consolidated basis the company reported net sales of JPY 1,059 million compared to JPY 957 million a year ago. Operating loss was JPY 1,008 million compared to JPY 2,714 million a year ago. Ordinary loss was JPY 995 million compared to JPY 2,700 million a year ago. Loss was JPY 795 million compared to JPY 3,127 million a year ago. Basic loss per share was JPY 6.71 compared to JPY 27.47 a year ago.
The company provided non consolidated earnings guidance for the year ending of September 2020. For the year, the company expects net sales to be of JPY 1,090 million. Operating loss expected to be of JPY 1,106 million. Ordinary loss expected to be of JPY 1,099 million. Loss expected to be of JPY 1,079 million. Basic loss per share expected to be of JPY 8.93.
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
Medinet Co., Ltd. Reports Earnings Results for the Period Ended September 30, 2019; Provides Non Consolidated Earnings Guidance for the Year Ending of September 2020